HEALTHWhy You Can Thank Millennials for the Booming $70 Billion Pet IndustryBy Melissa AngellAug 8, 2017 5:14 PM EDT
HEALTHCramer: Every time I see Pfizer quarter, I recognize why they needed to do the Allergen dealBy Melissa AngellAug 7, 2017 12:13 PM EDT
HEALTHNow That's a Switch: Longtime Tomato Grower to Fill Greenhouse With WeedBy Melissa AngellAug 5, 2017 1:40 PM EDT
HEALTH$AGN posted $4 billion in revenue in the aesthetics divisionBy Melissa AngellAug 3, 2017 3:15 PM EDT
HEALTHBored With Cream and Sugar? You Can Now Add Weed to Your Morning JoeBy Melissa AngellAug 1, 2017 2:33 PM EDT
INVESTINGBillionaire Mark Cuban: The Rise of Technology Will Cause a Lot of UnemploymentBy Melissa AngellJul 31, 2017 4:43 PM EDT
HEALTHThe Pharma Giant Reports its Earnings Tomorrow Morning.By Melissa AngellJul 31, 2017 4:03 PM EDT
HEALTHTeamsters Wary of McKesson's Promise to Split Top RolesBy Melissa AngellJul 27, 2017 5:59 PM EDT
HEALTHNow, You Can Buy Shares of Popular Pro-Pot Periodical High TimesBy Melissa AngellJul 27, 2017 3:59 PM EDT
MERGERS AND ACQUISITIONSThe "vote no" campaign led by the International Brotherhood of Teamsters against $MCK succeedsBy Melissa AngellJul 27, 2017 8:04 AM EDT
MERGERS AND ACQUISITIONSHospital Operators Sink Amid Healthcare ConfusionBy Melissa AngellJul 25, 2017 3:04 PM EDT
HEALTHTeamsters to Protest McKesson's Shareholder Meeting WednesdayBy Melissa AngellJul 24, 2017 4:57 PM EDT
HEALTHGene Editing Company Joins NASDAQ, Jumps Over 20% on First DayBy Melissa AngellJul 21, 2017 12:26 PM EDT
HEALTHKala Pharmaceuticals Joins NASDAQ, the Biotech IPOs Keep ComingBy Melissa AngellJul 20, 2017 11:36 AM EDT
BANKRUPTCYValeant is working to repay some $30 billion in debt.By Melissa AngellJul 17, 2017 6:20 PM EDT
STOCKSKonica and Ambry Pairing to Accelerate Precision MedicineBy Melissa AngellJul 15, 2017 10:40 AM EDT
MERGERS AND ACQUISITIONSKonica and Ambry Pairing to Accelerate Precision MedicineBy Melissa AngellJul 14, 2017 5:24 PM EDT
STOCKSMagellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole HealthBy Melissa AngellJul 13, 2017 11:38 AM EDT
HEALTHMove Over GMO's: IPO for Gene Editor Calyxt Launches Next WeekBy Melissa AngellJul 10, 2017 5:09 PM EDT
STOCKSBristol Myers vies to be king of immune-boosting cancer drugs with new trial updateBy Melissa AngellJul 9, 2017 8:38 PM EDT
HEALTH"There is no longer any cash at the fund level" Shkreli wrote to his investors.By Melissa AngellJun 30, 2017 3:07 PM EDT
STOCKSCould an exhaustive juror search be part of the Pharma Bro's master plan?By Melissa AngellJun 28, 2017 3:46 PM EDT
CORPORATE GOVERNANCEShkreli's Lawyer Attempts to Ban Press...AgainBy Melissa AngellJun 27, 2017 12:13 PM EDT
HEALTHThe jury selection process for Shkreli's trial got underway Monday and is expected to continue Tues.By Melissa AngellJun 26, 2017 6:39 PM EDT
HEALTHHey Big Pharma, Meet the Better Care Reconciliation ActBy Melissa AngellJun 22, 2017 12:19 PM EDT
HEALTHRegeneron Soars After Eye Drug Competitor Novartis Releases Positive DataBy Melissa AngellJun 20, 2017 5:50 PM EDT
MERGERS AND ACQUISITIONSLocal NYC Grocers Unhappy with Amazon-Whole Foods DealBy Melissa AngellJun 20, 2017 11:22 AM EDT
STOCKSThese products from Medical Marijuana are legal in all 50 statesBy Melissa AngellJun 17, 2017 12:20 PM EDT
HEALTHThere's a new biotech fund out there... and it's got $300 millionBy Melissa AngellJun 16, 2017 9:45 AM EDT
HEALTHEpizyme's eventual rebound may show promise with results from cancer drug.By Melissa AngellJun 15, 2017 4:10 PM EDT
HEALTHAstraZeneca drops partnership with Regulus after ditching drugBy Melissa AngellJun 13, 2017 1:12 PM EDT
HEALTHDepomed, Insys Shares Down After FDA Decision on Endo's Opana ERBy Melissa AngellJun 9, 2017 5:20 PM EDT
HEALTHHere's the technology that big banks, doctors, and startups are all usingBy Melissa AngellJun 7, 2017 4:49 PM EDT
HEALTHCan healthcare giant Integra continue to grow? Signs point to yes.By Melissa AngellJun 4, 2017 12:20 PM EDT
